Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mech Ageing Dev ; 133(11-12): 686-94, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-23146670

RESUMO

Replicative senescence in human diploid fibroblasts is characterised by an exhaustion of proliferative potential and permanent cell cycle arrest. During senescence, telomere shortening-generated DNA damage activates p53 pathway that upregulates cell cycle inhibitors, such as p21. Human p400 ATPase is a chromatin remodeller that plays a key role in the deposition of the histone variant, H2A.Z within the p21 promoter, repressing p21 gene expression. Decline of p400 ATPase in senescent IMR-90 cells prompted us to investigate structural changes in the chromatin of the p21 promoter during in vitro aging. Whereas doxorubicin treatment in early-passaged cells results in nucleosome density changes near the p53 binding sites of the p21 promoter, our studies show that senescent cells with a high p21 transcription activity had a comparable nucleosome distribution as unstressed young cells. However, H2A.Z that is highly enriched within the p21 promoter of young cells is depleted in senescent cells, suggesting that downregulation of p400 and loss of H2A.Z localisation play roles in relieving p21 gene repression in senescent IMR-90 cells. Taken together, our results indicate that age-dependent p400 downregulation and loss of H2A.Z localisation may contribute to the onset of replicative senescence through a sustained high rate of p21 transcription.


Assuntos
Adenosina Trifosfatases/química , Inibidor de Quinase Dependente de Ciclina p21/metabolismo , DNA Helicases/metabolismo , Proteínas de Ligação a DNA/metabolismo , Fibroblastos/metabolismo , Histonas/metabolismo , Apoptose , Sítios de Ligação , Linhagem Celular , Senescência Celular , Cromatina/metabolismo , Dano ao DNA , Genes p53 , Humanos , Nuclease do Micrococo/metabolismo , Nucleossomos/metabolismo , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Espécies Reativas de Oxigênio , Telômero/ultraestrutura , Proteína Supressora de Tumor p53/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA